deltatrials
Completed PHASE1 NCT00024492

Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer

Sponsor: INSYS Therapeutics Inc

Conditions Tumors
Interventions Liposome Encapsulated Mitoxantrone (LEM)
Updated 5 times since 2017 Last updated: Jun 2, 2011 Started: Aug 31, 2001 Completion: Jun 30, 2004

This PHASE1 trial investigates Tumors and is currently completed. INSYS Therapeutics Inc leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Aug 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • INSYS Therapeutics Inc
Data source: INSYS Therapeutics Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Columbus, United States
  • • Detroit, United States
  • • Duarte, United States
  • • Tampa, United States